KZR
Kezar Life Sciences Inc
0.175$
+6.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -288.6% | – | – | – | – | -1,614.7% | – | – | – | – | – | – | |
| – | 4.0% | – | – | – | – | 24.9% | – | – | – | – | – | – | |
| – | 94.8% | – | – | – | – | 317.4% | – | – | – | – | – | – | |
| – | -33.0% | – | – | – | – | 64.1% | – | – | – | – | – | – | |
| – | 1.9% | – | – | – | – | 1.1% | – | – | – | – | – | – | |
| – | 265.3% | – | – | – | – | 2,278.7% | – | – | – | – | – | – | |
| – | 0.6% | – | – | – | – | 4.5% | – | – | – | – | – | – | |
| – | -23.0% | – | – | – | – | 661.3% | – | – | – | – | – | – | |
| – | -290.6% | – | – | – | – | -1,615.7% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.